Skip to content
PeptideSport
TeleWellnessMD logo

Provider review

TeleWellnessMD review

By Derek Olsson ·

GLP-1 prices from $199.95 appear only on a catalog page, not in its marketing copy

Its GLP-1 prices — from $199.95 — appear only as "Starting at" figures on a catalog page, never in the marketing copy. That copy also never says these are compounded blends with B-vitamins or glycine mixed in rather than plain semaglutide.

Price verified

Straight talk: how we earn — some, not all, of these are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.

On this page

The verdict

TeleWellnessMD's real GLP-1 pricing exists and is genuinely competitive, but it appears only as "Starting at" figures on a catalog page — not in the site's own marketing copy, which never discloses that its GLP-1 products are actually compounded combination blends with added B-vitamins or glycine rather than single-ingredient medication.

TeleWellnessMD isn't on any of our comparisons yet. The providers we compare in this category are on our semaglutide provider ranking. Nothing on this page is a performance claim — see how semaglutide works for what the treatment does and does not do.

Alternatives to TeleWellnessMD

Other providers we work with. Compare prices before you sign up anywhere.

Who it is for, and who it is not

A good fit if

  • You want GLP-1 therapy bundled with a broader hormone and wellness catalog from an established, long-running platform
  • You're comfortable with compounded combination blends (semaglutide/tirzepatide plus B-vitamins or glycine) rather than single-ingredient medication
  • You want a published phone support line for questions before starting

Look elsewhere if

  • You want to see pricing in the site's own marketing copy — the real figures appear only on a separate catalog page
  • You want to know upfront that your medication will be a combination blend, not single-ingredient — this isn't disclosed clearly in the marketing copy
  • You want all sales to be refundable — this provider's policy is final-sale for compounded prescriptions

What it actually costs

What they advertise

Compounded Semaglutide/B-12 or Semaglutide/B-6 blends run $199.95-$299.95/month depending on dose, and Tirzepatide/Glycine up to $899.95 for a continuation vial — shown only as "Starting at" figures on its GLP-1 catalog page, not as a headline price in the site's marketing copy.

What you actually pay, month to month

$199.95-$299.95/month for semaglutide-based blends, or higher for tirzepatide tiers; shown only as "Starting at" figures on its GLP-1 catalog page, not as a headline figure in the marketing copy.

The commitment trap

The prices appear only as "Starting at" figures on a catalog page, never as a headline number in the marketing copy — many visitors will never see them.

Prices come from TeleWellnessMD's own website and can change without notice — confirm before you buy. Work out what a vial actually gives you with our peptide dose calculator.

What is included

Compare the total cost, including fees and any minimum commitment. Here is what TeleWellnessMD bundles in, and what it does not.

Clinician consult

Initial consultation required before any prescription purchase

no individual clinician is named — only generic 'licensed MDs, DOs, and ARNPs' language.

Bloodwork / labs

Not published

Follow-ups and dose changes

At least one semi-annual consultation required to renew a subscription

Human support

Published phone support line, (877) 659-6050

Injection supplies

Not published

Shipping

Not published

Pharmacy, labs and oversight

The pharmacy

Not currently displayed to visitors; a hidden logo carousel that visitors never see names several real compounding pharmacies, including Empower.

Oversight

At least one semi-annual consultation required to renew a subscription.

Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Our guide to verifying a certificate of analysis covers what to ask for.

Where you can get it

All 50 U.S. states, 'subject to provider licensure and applicable state laws.'

The honest cons

The part they would rather you skipped

TeleWellnessMD's GLP-1 pricing — starting at $199.95 — is never shown as a headline figure in the site's own marketing copy; you only find "Starting at" figures on a separate catalog page.

  • Real pricing appears only on a separate catalog page, not in the site's own marketing copy
  • GLP-1 products are compounded combination blends (with added B-vitamins or glycine), not disclosed clearly as such in marketing copy
  • No individual clinician or medical director named anywhere
  • All sales are final for compounded prescriptions

Weigh these trade-offs against the costs, care and terms above. For questions to ask before enrolling, see our vendor red-flags guide.

Similar providers

Read this before you buy

A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.

Provider offers and terms are based on TeleWellnessMD's public information. Other sources, where used, are identified in this review. Prices and terms change without notice — confirm on TeleWellnessMD's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.